2035818-21-2
2035818-21-2
Chemical Structure
(S)-Bexicaserin
Synonym(s): (S)-LP352
- CAS No.: 2035818-21-2
- Formula:C15H19F2N3O
- Molecular Weight:295.33
InChIKey: KGOOOHQKLRUVSF-SECBINFHSA-N
SMILES: FC(F)CNC(C1=C2C3=C(C=C1)CNCCN3C[C@H]2C)=O
Biological Activity: (S)-Bexicaserin ((S)-LP352) is the less active S-enantiomer of Bexicaserin (HY-15601). Bexicaserin is a 5-HT2C agonist with the potential to be used in the study of obesity and psychiatric-related diseases[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(S)-Bexicaserin | (S)-Bexicaserin ((S)-LP352) is the less active S-enantiomer of Bexicaserin (HY-15601). Bexicaserin is a 5-HT2C agonist with the potential to be used in the study of obesity and psychiatric-related diseases. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Albert S Ren, et al. 5-ht2c receptor agonists and compositions and methods of use. Patent WO2016176177A1.
- [2]. Preparation of 1,2,3,4,6,7-hexahydro[1,3]diazepino[6,7,1-hi]indole-8-carboxamides as 5-HT2C receptor agonists and compositions and therapeutic uses thereof. World Intellectual Property Organization, WO2016176177 A1 2016-11-03.
